Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models
David A. Proia(C4 Therapeutics (United States)), Yumiko Wada(University of Tsukuba)
Cited by 79
Related Papers
The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer
|Investigational New Drugs|2014|73
Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expression
|International Journal of Oncology|2012|60
Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypes
|Investigational New Drugs|2013|58